Watch Compass Therapeutics CEO Thomas Schuetz, MD, PhD, present live at the 2026 Stifel Virtual Targeted Oncology Forum.
• Date: Wednesday, May 20, 2026
• Time: 11:30 a.m. ET
➜ Register now: https://t.co/bf2KxHssud
#CMPX#biopharmaceutical#therapeutics#immunotherapy
Join Thomas Schuetz, MD, PhD, CEO of Compass Therapeutics, for a live webcast at the H.C. Wainwright 4th Annual BioConnect Investor Conference.
• Date: Tuesday, May 19, 2026
• Time: 12:00 p.m. ET
➜Register now: https://t.co/UonMhyJDey
#CMPX#biopharmaceutical#therapeutics #immunotherapy
We were proud to attend the Cholangiocarcinoma Foundation 2026 Annual Conference in Salt Lake City, May 1–3, joining CCF in celebrating its 20th anniversary and honoring the cholangiocarcinoma community.
The conference brought together patients, caregivers, advocates, clinicians, researchers, and industry colleagues for important conversations about advancing research and care for patients with biliary tract cancer.
Congratulations to CCF on 20 years of leadership, support, and impact.
@curecc #Cholangiocarcinoma #BiliaryTractCancer #CCF2026 #CancerResearch #PatientAdvocacy
Over the weekend was International Women’s Day and today we want to share our appreciate for the incredible women advancing innovation in science!
From the lab to the clinic, their leadership, skill, and dedication help drive our mission to develop new therapies for people living with cancer.
#InternationalWomensDay #WomenInScience #WomenInBiotech
Join us in welcoming Craig Bodycombe to Compass as Director of Analytical Development.
Craig brings 20 years of progressive experience in the biotechnology and pharmaceutical industries, specializing in protein therapeutics, including more than 10 years working with monoclonal antibodies.
#CMPX #biopharmaceutical #therapeutics #immunotherapy
Cholangiocarcinoma (CCA) Awareness Month reminds us of the progress made—and the work that remains.
CCA is an aggressive cancer with significant unmet need—especially for patients facing advanced disease.
At Compass Therapeutics, we’re focused on translating science into meaningful progress for patients, including those facing hard-to-treat cancers. We are proud to stand with the Cholangiocarcinoma Foundation, honoring the entire CCA community—patients, caregivers, clinicians, researchers, and advocates—who keep moving forward, together. To learn more, visit: https://t.co/dHXGxkxfFY
#Cholangiocarcinoma #CCAMonth #CureCCA #CCAHope #CancerAwareness #Oncology #Biotech #Research
Please welcome Varsha Menon to the Compass team as our Director of Biometrics!
Varsha brings deep experience as a Biometrics Lead, Oncology TA partner, and in patient advocacy.
#CMPX#biopharmaceutical#therapeutics#immunotherapy
Join us at the 44th Annual J.P. Morgan Healthcare Conference for a live presentation and webcast with Thomas Schuetz, MD, PhD, CEO of Compass Therapeutics.
Location: San Francisco
Date: Wednesday, January 14, 2026
Time: 7:30–8:10 a.m. PT
Register now to watch live or on demand at https://t.co/KFZaYZA2wB.
#CMPX #biopharmaceutical #therapeutics #immunotherapy
Compass Therapeutics announces the appointments of Arjun Prasad, MBA, MPH, as Chief Commercial Officer, and Cynthia Sirard, MD, as Chief Medical Officer.
“We are thrilled to welcome Arjun and Cyndi to the Compass team. They are highly accomplished leaders with decades of commercial and clinical development experience,” said Thomas Schuetz, MD, PhD, Compass CEO and Board Vice Chairman.
Read the news release at https://t.co/gr6UxLrEps.
#CMPX #biopharmaceutical #therapeutics #immunotherapy
Join us at the 44th Annual J.P. Morgan Healthcare Conference for a live presentation and webcast with Thomas Schuetz, MD, PhD, CEO of Compass Therapeutics.
Location: San Francisco
Date: Wednesday, January 14, 2026
Time: 7:30–8:10 a.m. PT
Register now to watch live or on demand at https://t.co/KFZaYZA2wB.
#CMPX #biopharmaceutical #therapeutics #immunotherapy
Don’t miss tomorrow’s live presentation and webcast from Compass Therapeutics CEO Thomas Schuetz, MD, PhD, at the 8th Annual Evercore Healthcare Conference.
Location: Coral Gables, FL
Date: Thursday, Dec. 4, 2025
Time: 10:00 a.m. ET
Register now to view the live webcast: https://t.co/jIl0yTVzO5.
#CMPX #biopharmaceutical #therapeutics #immunotherapy
Tomorrow — Join Compass Therapeutics CEO Thomas Schuetz, MD, PhD, for a live presentation and webcast at the Piper Sandler 37th Annual Healthcare Conference.
Location: New York City
Date: Tuesday, Dec. 2
Time: 8 a.m. ET
Register now to view the live webcast: https://t.co/XUiJRWSazB.
#CMPX #biopharmaceutical #therapeutics #immunotherapy
Today — Join Compass Therapeutics CEO Thomas Schuetz, MD, PhD, for a presentation at the Jefferies Global Healthcare Conference in London.
When:
• Today - Thurs., Nov. 20
• 12:30 p.m. GMT
Register now to view the live webcast: https://t.co/PuHqbS92nz
#CMPX #biopharmaceutical #therapeutics #immunotherapy #JefferiesHealthcare
Today!
Watch Thomas Schuetz, MD, PhD, and CEO, Compass Therapeutics, present at the Stifel 2025 Healthcare Conference in New York City.
When:
• Today - Wed., Nov. 12
• 4 p.m. ET
Register now to view the live webcast: https://t.co/nZ388hpSyb
#CMPX#biopharmaceutical #therapeutics #immunotherapy
Today!
Join Compass Therapeutics CEO Thomas Schuetz, MD, PhD, for a presentation at the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston.
When:
• Today - Monday, Nov. 10
• 3:30 p.m. ET
Register now to view the live webcast: https://t.co/FFOCqvV0j9
#CMPX #biopharmaceutical #therapeutics #immunotherapy
Join us as we present preclinical data on CTX-10726, a differentiated PD-1 x VEGF-A bispecific antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting.
Presentation Details:
* Title: Preclinical Development of CTX-10726, a Tetravalent Bispecific Antibody Targeting PD-1 and VEGF-A for the Treatment of Patients with Cancer
* Date/Time: Nov. 7, at 12:15 pm and 5:35 pm
* Abstract number: 1151
* Presenter: Diana Albu, PhD, Associate Director
* Location: Exhibit Halls AB
Read the news release at https://t.co/agnUW7d1Bx.
#SITC25 #CMPX #biotech #biopharmaceutical #therapeutics #immunotherapy
Join us as we participate in these investor events during November:
* Guggenheim 2nd Annual Healthcare Innovation Conference
Boston, Mass.
Monday, Nov. 10 at 3:30 pm ET
Webcast: https://t.co/LR7gWxM1oE
* Stifel 2025 Healthcare Conference
New York, N.Y.
Wednesday, Nov. 12 at 4:00 pm ET
Webcast: https://t.co/zUOyA8GoP3
* Jefferies Global Healthcare Conference
London, U.K.
Thursday, Nov. 20 at 12:00 pm GMT
Webcast: https://t.co/FGOZFvabil
The presentations will be available for virtual replay for 90 days at https://t.co/JyWmlnjU1A.
Read the news release at https://t.co/nXmtvHAHv1
#CMPX #biotech #biopharmaceutical #therapeutics #immunotherapy
At Compass Therapeutics, our mission is clear: to develop next-generation antibodies into cancer therapies that improve patients’ lives.
Our team thrives on collaboration, creativity, and passion — because big goals demand bold science and bold people.
Join us — to grow, contribute, and make an impact that matters.
-> Explore our current opportunities: https://t.co/SBOYk7bw4V
Join us tomorrow for a fireside chat at:
→ Morgan Stanley 23rd Annual Global Healthcare Conference
New York City
Tuesday, Sept. 9, 2025
5:35 p.m. ET
Register and view live online at https://t.co/uzQv3Qb64n.
See the virtual replay for 90 days at https://t.co/stk8LEfqVM.
#CMPX
Join us Monday as we host a company presentation at:
→ H.C. Wainwright 27th Annual Global Investment Conference
New York City
Mon., Sept. 8, 2025
11 am ET
Register & view live online at https://t.co/1T78B8kKfV
See the virtual replay for 90 days at https://t.co/stk8LEfqVM
#CMPX